Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma
Clinical trial NCT03710603 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03710603
- Sponsor
- Stichting European Myeloma Network
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-14
- Primary completion
- 2023-08-01
- Enrollment
- 709
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.